These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10231779)

  • 21. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):10-2. PubMed ID: 16455008
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of hypolipemic agents on levels of total plasma homocysteine].
    Dvoráková J; Dubská L; Táborský L; Hyánek J
    Vnitr Lek; 2001 Oct; 47(10):674-7. PubMed ID: 11789004
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug treatment of hypercholesterolaemia. Determine cardiac risk.
    Capps N; Hartland A
    BMJ; 1994 Jan; 308(6920):56-7. PubMed ID: 8298358
    [No Abstract]   [Full Text] [Related]  

  • 25. Fish oil supplements.
    Med Lett Drugs Ther; 2006 Jul; 48(1239):59-60. PubMed ID: 16841020
    [No Abstract]   [Full Text] [Related]  

  • 26. [Substantiation of increasing doses of statins in clinical practice].
    Susekov AV
    Ter Arkh; 2001; 73(4):76-80. PubMed ID: 11494456
    [No Abstract]   [Full Text] [Related]  

  • 27. [Goal in hypercholesterolemia: lowering LDL cholesterol level by 50%].
    MMW Fortschr Med; 2005 Jul; 147(27-28):51. PubMed ID: 16041948
    [No Abstract]   [Full Text] [Related]  

  • 28. [What should be the role of antilipemic agents in the control of hypercholesterolemia in elderly persons?].
    Champoux N; Latour J
    Union Med Can; 1994 Feb; 123(2):91-4. PubMed ID: 8203037
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic syndrome, diabetes and coronary heart disease.
    Haffner SM
    Int J Clin Pract Suppl; 2002 Oct; (132):31-7. PubMed ID: 12425361
    [No Abstract]   [Full Text] [Related]  

  • 30. FM-VP4 Forbes Medi-Tech.
    Burnett JR
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1120-5. PubMed ID: 14582458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipids and their role in coronary heart disease: what they do and how to manage them.
    Pradka LR
    Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol treatment guidelines update.
    Safeer RS; Ugalat PS
    Am Fam Physician; 2002 Mar; 65(5):871-80. PubMed ID: 11898959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
    Krempf M; Rohmer V; Farnier M; Issa-Sayegh M; Corda C; Sirugue I; Gerlinger C; Masseyeff-Elbaz MF
    Diabetes Metab; 2000 May; 26(3):184-91. PubMed ID: 10880891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.
    Brohet C; Banai S; Alings AM; Massaad R; Davies MJ; Allen C
    Curr Med Res Opin; 2005 Apr; 21(4):571-8. PubMed ID: 15899106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.
    Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES
    J Am Coll Cardiol; 2005 Jan; 45(2):185-97. PubMed ID: 15653014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A randomized, double-blind, placebo-controlled study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia].
    Tedeschi-Reiner E; Reiner Z; Romić Z; Ivanković D
    Lijec Vjesn; 2005; 127(11-12):273-9. PubMed ID: 16583932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypercholesterolemia. The NCEP Adult Treatment Panel III Guidelines.
    Morgan JM; Capuzzi DM
    Geriatrics; 2003 Aug; 58(8):33-8; quiz 41. PubMed ID: 12938250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.